• Sign Up

Oxygen Administration


Oxygen Administration

Article Author:
Manuel Weekley
Article Editor:
Lauren Bland
Updated:
4/30/2020 9:06:34 PM
For CME on this topic:
Oxygen Administration CME
PubMed Link:
Oxygen Administration

Introduction

Clinicians initiate oxygen administration for a variety of reasons. Increased metabolic demand, maintenance of oxygenation while providing anesthesia, supplementation during treatment of lung illnesses that affect oxygen exchange, treatment of headaches, carbon monoxide exposure, and more are examples of reasons for its initiation. At sea level, the atmosphere consists of approximately 21 percent oxygen. As altitude increases, the percent of oxygen in the air decreases in a near-linear fashion. Adding supplemental oxygen or oxygen that is above the amount found in the atmosphere without alteration is most commonly delivered to the patient by nasal cannula, O2 mask (simple, non-rebreather, Venti-mask) or added into a CPAP (continuous positive airway pressure) or BiPAP (bilevel positive airway pressure) system. The ventilator provides oxygen for intubated patients.

Anatomy and Physiology

Each patient's airway anatomy merits consideration to achieve optimal oxygenation of a patient.  For example, a trauma patient with nasal passages occluded by blood would be sub-optimally provided supplemental oxygen using a nasal cannula, while for a patient with micrognathia, it might be challenging to achieve oxygenation goals using a sealed mask such as a CPAP or BiPAP system.

Oxygenation is optimal in an upright position, and awake patients requiring oxygenation support should be upright unless a contraindication to such positioning is present, contraindications include trauma before c-spine clearance, anatomy, patient risk and level of sedation. 

Indications

The most readily accepted indication for supplemental oxygenation is hypoxemia or decreased levels of oxygen in the blood. For the otherwise healthy patient, oxygen saturations targets are generally at 92 to 98%. For patients with chronic hypercapnic conditions, target oxygen saturations are generally between 88 to 92%, with oxygen administration indicated at saturations below these levels. This value is commonly measured with pulse oximetry, but a pulse oximeter can give falsely elevated readings in cases of anemia, cyanide, or carbon monoxide poisoning, and is not an adequate indicator of perfusion, as seen in cases of shock.

Chronic

  • COPD
  • Cystic fibrosis
  • Pulmonary fibrosis
  • Sarcoidosis

Acute

  • Medical emergencies requiring high concentrations of oxygen in all cases:
    • Shock
    • Sepsis
    • Major trauma
    • Cardiac arrest and during resuscitation
    • Anaphylaxis
    • Carbon Monoxide and cyanide poisonings
    • Transfusion-related acute lung injury (TRALI)
  • Medical emergencies which may or may not require oxygen administration
    • Asthma
    • Bronchitis
    • Acute heart failure, or heart failure exacerbations
    • Pulmonary embolism

It is worth noting that historically, acute myocardial infarction (AMI) receives treatment with morphine, oxygen administration, nitroglycerin, and aspirin; however, recent studies have shown routine oxygen administration to be non-beneficial.[1]

Contraindications

Paraquat, a common herbicide, is toxic to humans, and poisoning by this substance is worsened by oxygen therapy due to its redox activity.[2]

Carbon dioxide narcosis In patients with conditions such as obstructive pulmonary disorders, or chronic respiratory insufficiency that result in hypercarbia, over-administration of oxygen may reduce the respiratory drive.  This reduction can result in further hypercarbia, altered mental status, or even complete respiratory collapse. Titrated therapy in hypoxemic patients with obstructive respiratory disease should merit consideration.[3]

Neonates exposed to high levels of oxygen are at risk for developing retinopathy of prematurity, or ROP, as the oxygen promotes neovascularization of the retinas, and can cause vision loss or blindness. Administration of vitamin E to premature neonates and antioxidants in adults may provide some protection for those infants requiring supplemental oxygenation.[4][5][4]

Oxygen is highly flammable, and thus it poses a fire risk with use in proximity to open flames; this is particularly important in those patients who are having treatment for lung conditions associated with smoking, such as COPD. Concurrent use of supplemental oxygen and cigarettes can result in damage to person and property for oxygen users. Care is necessary with all flames, and careful storage of oxygen tanks is essential for patient safety.

Oxygen administration can increase insensible losses due to the use of dry (non-humidified) air, particularly at high flow rates. Additionally, in vulnerable patients, the administration of cool or even cold oxygen can increase the risk of hypothermia; this is easily mitigated by humidification and warming before administration.

Oxygen toxicity is an iatrogenic illness caused by exposure to high FIO2 during oxygen therapy. Oxygen saturation should be monitored in patients receiving supplemental O2. As the oxygen gets metabolized, some molecules convert to superoxide anions known as hydroxyl radicals, which are human tissue toxic. The resulting pathophysiological changes at the alveolar level result in decreases in lung compliance, diffusing capacity, and PaO2 levels. CNS toxicity can occur with exposure to high partial pressures of oxygen. Acute changes in the lungs resulting from oxygen toxicity consist of alveolar and interstitial edema, alveolar hemorrhages, and proteinaceous exudates. Further prolonged exposure to oxygen leads to a proliferative phase, which includes the proliferation of type II epithelial cells and fibroblasts, followed by collagen deposits. Exposure to FIO2s greater than 0.60 for as little as 24to 48 hours can lead to severe irreversible pulmonary fibrosis.[6][7]

Equipment

Low Flow Administration

  • Nasal Cannula - a thin tube, often affixed behind the ears and used to deliver oxygen directly to the nostrils from a source connected with tubing. This is the most common method of delivery for home use and provides flow rates of 2 to 6 liters per minute (LPM) comfortably, allowing the delivery of oxygen while maintaining the patient’s ability to utilize his or her mouth to talk, eat, etc.
  • Transtracheal catheters - these are used in chronic maintenance therapy and represent a method of oxygenation in which a catheter is surgically inserted through the anterior neck to deliver oxygen directly to the trachea, thus bypassing the upper airway.[8] By bypassing the upper airway, oxygen delivery is closer to the alveoli, bypassing the dead space in the upper airway and allowing for chronic use of lower amounts of oxygen without reducing the amount of supplemental oxygen delivered to the lungs. This arrangement allows for more extended use of supplemental oxygen, and allows the patient to be away from home for longer periods, but does require surgical placement, with potential for site infection, irritation, and complications common to such procedures.[9]
  • Face Masks - facemasks can be generally divided into simple facemasks, air-entrainment masks, and non-rebreathers. A simple facemask is a mask with no bag attached, which delivers oxygen at 5 to 8 LPM. An air-entrainment (also known as venturi) mask can provide a pre-set oxygen to the patient using jet mixing. As the percent of inspired oxygen increases using such a mask, the air to oxygen ratio decreases, causing the maximum concentration of oxygen provided by an air-entrainment mask to be around 40%. A disadvantage of this and other full face masks is the inability of the patient to eat, drink, or easily communicate while using such a device.
  • Non-rebreathing masks have a bag attached to the mask known as a reservoir bag, which inhalation draws from to fill the mask through a one-way valve and features ports at each side for exhalation, resulting in an ability to provide the patient with 100% oxygen at a higher LPM flow rate.
    • A reservoir bag is an attachment to an oxygen administration device that allows for the concentration of oxygen, and thus increased percentage administration. By allowing the collection of 100% O2 in a reservoir bag, the patient may receive a higher concentration of oxygen by reducing the percent of inhaled gas made up of atmospheric oxygen.

High Flow Administration

  • High flow nasal cannula (HFNC) is a nasal cannula with the capability of humidifying oxygen, and also capable of flow rates that exceed the inspiratory pressure of the patient. This setup allows delivery of 100% Fi02 while maintaining the patient’s ability to utilize the mouth to talk, eat, etc. HFNC may also be used to lengthen times of apnea in preparation for intubation.[10]

Positive Pressure

  • Continuous positive airway pressure, or CPAP, is a mask that delivers continuous positive pressure to the patient.
  • Similarly, bilevel positive airway pressure or BiPAP is also positive pressure delivered via mask but has an inhale, and an exhale pressure set at differing levels.
  • Bag-mask devices, or BVM’s, are masks operated by hand for resuscitation when patients cannot breathe on their own and can connect to oxygen sources for increased levels of oxygen delivery.
  • Ventilators are machines that breathe for a patient, either through a tracheostomy or endotracheal tube. The ventilator can have oxygen delivery titrated to specific patient needs, and delivered through positive pressure to the patient. Endotracheal tubes possess the added advantage of occluding the airway, thus preventing aspiration of blood, secretions, etc. in patients unable to protect their own airways.

Other 

  • Neonatal incubators also provide oxygen supplementation and do so through increasing the concentration of oxygen in the interior chamber without directly applying oxygen to the patient. This differs from other forms of oxygenation in that the atmosphere in a controlled environment is changed rather than oxygen administered to the patient, although more traditional forms of oxygenation may also be an option.[11]

Clinical Significance

Oxygen administration is one of the most common interventions in the acute care setting and is indicated in a wide variety of acute and chronic medical conditions.  Health care professionals should be familiar with routes of oxygen administration, as well as the physiological effects of oxygen administration as a fundamental part of patient care.

Enhancing Healthcare Team Outcomes

Teams should be familiar with multiple modalities of oxygen administration, their initiation, and use, as well as limitations of each modality.  Although a clinician may order a specific type of oxygen administration and initially be the most appropriate, individual patients change, and their medical conditions evolve. Constant re-evaluation of the patient is critical to ensure that continued oxygen administration is necessary, as well as the route is the best possible for each patient.  Respiratory therapists are often the team members initiating and monitoring methods of oxygenation, and vigilance from the respiratory therapist is vital in ensuring that the patient receives optimal therapy.  Additionally, nurses, medical techs, and all other members of the team have a role to play in vigilant monitoring of the patient requiring acute oxygen administration for optimal patient-centered care.  Patients placed on oxygen supplementation should have vigilant monitoring by pulse oximetry, and the patient's oxygen administration should undergo titration to parameters set forth by the patient's care team based on most current evidence-based guidelines for each disease process. An interprofessional approach for patients receiving oxygen will result in the best outcomes. [Level 5]


References

[1] Abuzaid A,Fabrizio C,Felpel K,Al Ashry HS,Ranjan P,Elbadawi A,Mohamed AH,Barssoum K,Elgendy IY, Oxygen Therapy in Patients with Acute Myocardial Infarction: A Systemic Review and Meta-Analysis. The American journal of medicine. 2018 Jun;     [PubMed PMID: 29355510]
[2] Dinis-Oliveira RJ,Duarte JA,Sánchez-Navarro A,Remião F,Bastos ML,Carvalho F, Paraquat poisonings: mechanisms of lung toxicity, clinical features, and treatment. Critical reviews in toxicology. 2008;     [PubMed PMID: 18161502]
[3] Austin MA,Wills KE,Blizzard L,Walters EH,Wood-Baker R, Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial. BMJ (Clinical research ed.). 2010 Oct 18;     [PubMed PMID: 20959284]
[4] Reynolds JD, The management of retinopathy of prematurity. Paediatric drugs. 2001;     [PubMed PMID: 11354698]
[5] Perrone S,Bracciali C,Di Virgilio N,Buonocore G, Oxygen Use in Neonatal Care: A Two-edged Sword. Frontiers in pediatrics. 2016     [PubMed PMID: 28119904]
[6] Thomson L,Paton J, Oxygen toxicity. Paediatric respiratory reviews. 2014 Jun;     [PubMed PMID: 24767867]
[7] Helmerhorst HJF,Schouten LRA,Wagenaar GTM,Juffermans NP,Roelofs JJTH,Schultz MJ,de Jonge E,van Westerloo DJ, Hyperoxia provokes a time- and dose-dependent inflammatory response in mechanically ventilated mice, irrespective of tidal volumes. Intensive care medicine experimental. 2017 Dec     [PubMed PMID: 28550659]
[8] Christopher KL,Schwartz MD, Transtracheal oxygen therapy. Chest. 2011 Feb     [PubMed PMID: 21285058]
[9] Siddiqui FM,Campbell S,Ie S,Biscardi F,Rubio E, Three decades of transtracheal oxygen therapy: A review of the associated complications with an illustrative case presentation. Lung India : official organ of Indian Chest Society. 2017 Sep-Oct     [PubMed PMID: 28869230]
[10] Wong DT,Dallaire A,Singh KP,Madhusudan P,Jackson T,Singh M,Wong J,Chung F, High-Flow Nasal Oxygen Improves Safe Apnea Time in Morbidly Obese Patients Undergoing General Anesthesia: A Randomized Controlled Trial. Anesthesia and analgesia. 2019 Oct     [PubMed PMID: 31584919]
[11] Travers CP,Carlo WA,Nakhmani A,Bhatia S,Gentle SJ,Amperayani VA,Indic P,Aban I,Ambalavanan N, Environmental or Nasal Cannula Supplemental Oxygen for Preterm Infants: A Randomized Cross-Over Trial. The Journal of pediatrics. 2018 Sep     [PubMed PMID: 29705116]